Why We Age: The Biology of Senescence and What Science Is Learning to Do About It

---
title: Why We Age: The Biology of Senescence and What Science Is Learning to Do About It
slug: aging-biology-2026
tags: biology,aging,longevity,science,medicine
---

# Why We Age: The Biology of Senescence and What Science Is Learning to Do About It

Aging is so universal that it can seem like a simple fact of nature — something that just happens, like gravity or entropy. But from a biological standpoint, aging is a complex, multi-causal process that researchers are only beginning to understand in mechanistic detail. And as that understanding deepens, the once-fanciful idea of meaningfully extending healthy human lifespan is being taken seriously by mainstream biology for the first time.

## The Hallmarks of Aging

The landmark 2013 paper by López-Otín and colleagues identified nine "hallmarks of aging" — biological processes that decline or go wrong as organisms grow old and that, when induced experimentally in young animals, accelerate aging. The list has since been revised and extended, but the core hallmarks include:

**Genomic instability**: DNA damage accumulates throughout life. Cells have repair mechanisms, but these are imperfect, and damage builds up over decades. Mutations in somatic cells contribute to cancer risk and may impair tissue function more broadly.

**Telomere shortening**: Telomeres — protective caps on chromosome ends — shorten with each cell division. Critically short telomeres trigger cells to enter senescence or undergo programmed death, reducing the pool of functional cells in aging tissues.

**Cellular senescence**: Cells that have stopped dividing (senescent cells) don't simply die — they persist and secrete a cocktail of inflammatory molecules called the senescence-associated secretory phenotype (SASP). A few senescent cells are beneficial for wound healing; an accumulation over decades creates chronic low-grade inflammation ("inflammaging") that drives many age-related conditions.

**Mitochondrial dysfunction**: Mitochondria — the cellular energy factories — accumulate damage and become less efficient with age. This reduces cellular energy production and increases oxidative stress.

## What Interventions Are Being Explored

The most established intervention remains caloric restriction, which extends healthy lifespan in nearly every organism it has been tested in, from yeast to mice. The mechanisms involve metabolic pathways — particularly mTOR inhibition and AMPK activation — that appear to activate cellular maintenance programs when food is scarce. Rapamycin, which inhibits mTOR, extends lifespan in mice even when started in mid-life and is attracting intense research interest despite concerns about immune suppression.

Senolytics — drugs that selectively eliminate senescent cells — have produced dramatic results in animal models. In mice, periodic clearance of senescent cells delays the onset of multiple age-related conditions and extends healthy lifespan. Early human clinical trials are underway, with initial results cautiously encouraging for specific conditions. The Dasatinib+Quercetin combination has shown some effects in early trials.

Epigenetic reprogramming is the most ambitious frontier. Yamanaka factors — the four transcription factors that can reprogram adult cells into induced pluripotent stem cells — can also be used in partial reprogramming to reverse epigenetic aging markers without full dedifferentiation. In animal models, partial reprogramming restores aspects of youthful function to old cells and tissues. Companies like Altos Labs are investing hundreds of millions of dollars in this approach.

## The Honest Assessment

None of these interventions have yet demonstrated meaningful lifespan extension in humans, and translating rodent results to humans has historically been difficult. The biology of human aging is more complex and less tractable than that of short-lived model organisms. But the pace of mechanistic understanding is accelerating, and the field has moved from observational correlation toward causal intervention in ways that would have seemed speculative a decade ago. Whether meaningful healthspan extension for humans is decades away or centuries away remains genuinely uncertain.

Why We Age: The Biology of Senescence and What Science Is Learning to Do About It

// COMMENTS

ON THIS PAGE